Health Care & Life Sciences » Biotechnology | ProMetic Life Sciences Inc.

ProMetic Life Sciences Inc.

ProMetic Life Sciences Inc.
Stock Exchange Other OTC
EPS
$0.2
Market Cap
$337.37 M
Shares Outstanding
718.13 M
Public Float
-
ProMetic Life Sciences Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
718.13 M
Public Float
-
ProMetic Life Sciences Inc.
Stock Exchange Toronto Stock Exchange Prices
EPS
CAD262.7
Market Cap
CAD399.36 M
Shares Outstanding
23.22 B
Public Float
559.92 M

Profile

Address
440 Armand-Frappier Boulevard
Laval Québec H7V 4B4
Canada
Employees -
Website http://www.prometic.com
Updated 07/04/2019
Prometic Life Sciences, Inc. engages in the development of therapeutic products focusing on unmet medical needs in the field of fibrosis, autoimmune disease or inflammation, and cancer. It operates through the following segments: Bioseparations, Plasma-derived Therapeutics, and Small Molecule Therapeutics. The Bioseparations segment is involved in large-scale purification of biologics and the elimination of pathogens.

Financials

View All
Created with Highcharts 5.0.14ProMetic Life Sciences Inc.Net Income. Fiscal year is January-December. All values CAD Thousands.16 48916 4895 9395 93950 96150 961100 807100 807109 731109 73120132014201520162017025k50k75k100k125k
Created with Highcharts 5.0.14ProMetic Life Sciences Inc.Sales/Revenue. Fiscal year is January-December. All values CAD Thousands.20 64420 64423 01023 01024 53424 53416 39216 39239 11539 11547 37447 374201320142015201620172018010k20k30k40k50k

Pierre Laurin
President, CEO & Non-Independent Director
Bruce J. Wendel
Non-Independent Director